Sie suchten nach: Boc-trans-4-amino-L-proline methyl ester hydrochloride salt
221 results were found
Upstream processing for cell therapy
/cms/de/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Fine Chemicals from Alfa Aesar & Acros Organics
/cms/de/acros_organics_page
Fine Chemicals from Alfa Aesar & Acros Organics The Acros Organics and Alfa Aesar brands provide an extensive range of chemicals functional reagents organic building blocks metals and life science reagents for research and development and quality ...
Upstream processing for mAbs
/cms/de/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/fr/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/de/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/it/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Upstream processing for cell therapy
/cms/fr/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Upstream processing for cell therapy
/cms/it/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Aurora Manufacturing Facility
/cms/de/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
Aurora Manufacturing Facility
/cms/it/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
Upstream processing for mAbs
/cms/fr/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Upstream processing for mAbs
/cms/it/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Aurora Manufacturing Facility
/cms/fr/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-v
/m-ch.vwr.com/fr_CH/images/build_you_own_chiral_column.pdf
(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-vs2_BP \(005\).PPTX [Read-Only]) Benjamin Peters Tom Kupfer Gisela Jung Peter Knoell Egidijus Machtejevas Petra Lewits Juni 2018 via immobilization ...
(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-v
/m-ch.vwr.com/it_CH/images/build_you_own_chiral_column.pdf
(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-vs2_BP \(005\).PPTX [Read-Only]) Benjamin Peters Tom Kupfer Gisela Jung Peter Knoell Egidijus Machtejevas Petra Lewits Juni 2018 via immobilization ...
(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-v
/m-ch.vwr.com/de_CH/images/build_you_own_chiral_column.pdf
(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-vs2_BP \(005\).PPTX [Read-Only]) Benjamin Peters Tom Kupfer Gisela Jung Peter Knoell Egidijus Machtejevas Petra Lewits Juni 2018 via immobilization ...
17 - 32 of 221